Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Non-Current Assets (2016 - 2021)

Phio Pharmaceuticals' Non-Current Assets history spans 10 years, with the latest figure at $493000.0 for Q3 2021.

  • For Q3 2021, Non-Current Assets fell 20.36% year-over-year to $493000.0; the TTM value through Sep 2021 reached $2.1 million, down 22.62%, while the annual FY2020 figure was $575000.0, 22.19% down from the prior year.
  • Non-Current Assets reached $493000.0 in Q3 2021 per PHIO's latest filing, down from $502000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $787000.0 in Q3 2019 to a low of $132000.0 in Q1 2017.
  • Average Non-Current Assets over 5 years is $468421.1, with a median of $502000.0 recorded in 2021.
  • Peak YoY movement for Non-Current Assets: plummeted 36.82% in 2018, then skyrocketed 329.65% in 2019.
  • A 5-year view of Non-Current Assets shows it stood at $266000.0 in 2017, then plummeted by 35.34% to $172000.0 in 2018, then surged by 329.65% to $739000.0 in 2019, then fell by 22.19% to $575000.0 in 2020, then fell by 14.26% to $493000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Non-Current Assets are $493000.0 (Q3 2021), $502000.0 (Q2 2021), and $534000.0 (Q1 2021).